2,6-Dichlorobenzenesulfonamide, 97.0%, 1g

2-(2-(2-FLUOROPHENYL)-2-OXOETHYL)MALONONITRILE, 97%, 1g

Ethyl 5-amino-6-methylnicotinate, 95.0%, 100mg

N-methyl-1-[3-(2-pyridinyl)-5-isoxazolyl]methanamine dihydrochloride, 95.0%, 1g

1-butyl-2,3,3-trimethyl-3H-indol-1-ium iodide, 95.0%, 250mg

5-FLUOROQUINOXALINE, 95.0%, 10g

GC capillary column ROTI®Cap-1701, 60 m, 0.32 mm, 0.25 µm, 1 Piece(s)

tert-Butyl (2-(4-cyanophenyl)-2-oxoethyl)carbamate, 5g

(2E)-3-(3,4-dimethoxyphenyl)-1-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

Tris(4-chlorophenyl)phosphine>97.0%(GC)25g

3-Methoxy-4-nitropyridine, 98+%, 100mg

(S)-2-Amino-3-(4-(tert-butyl)phenyl)propanoic acid, 95.0%, 10g

3-Bromoquinolin-6-amine, 95.0%, 10g